business / news / / NDTV Profit
Sun Pharmaceutical Industries Ltd. shares jumped over 5% during early trade on Monday.
Sun Pharma will acquire Organon & Co. in an all-cash deal valued at $11.75 billion.
KEY POINTS
- The acquisition price is $14 per Organon share, totaling about $3.99 billion in equity value.
- Sun Pharma aims to complete the deal by early 2027, pending regulatory and shareholder approval.
- Funding will come from $2-2.5 billion cash and $9.25-9.75 billion from bank financing.
COMPANIES
Summarized by Newsio from NDTV Profit. How we summarize →